We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

48 hedge funds and large institutions have $158M invested in Cogent Biosciences in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

17% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 12

9% more funds holding

Funds holding: 44 → 48 (+4)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.07% less ownership

Funds ownership: 12.88% → 12.82% (-0.07%)

26% less capital invested

Capital invested by funds: $212M → $158M (-$54.5M)

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
1.1%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
14
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$989K
2
CI
Cowen Inc
New York
+$970K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$720K
4
State Street
State Street
Massachusetts
+$630K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$434K

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.15M
2
PIM
Platinum Investment Management
Australia
-$695K
3
Jennison Associates
Jennison Associates
New York
-$638K
4
BlackRock
BlackRock
New York
-$635K
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$576K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$208K -$69.2K -1,227 -20%
Squarepoint
27
Squarepoint
New York
$200K +$273K +4,850 New
Wells Fargo
28
Wells Fargo
California
$166K -$338 -6 -0.1%
Jane Street
29
Jane Street
New York
$150K +$205K +3,630 New
AllianceBernstein
30
AllianceBernstein
Tennessee
$138K +$40.9K +725 +28%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$135K +$12K +213 +7%
Goldman Sachs
32
Goldman Sachs
New York
$130K -$268K -4,760 -60%
UBS Group
33
UBS Group
Switzerland
$87K +$72.1K +1,279 +154%
Barclays
34
Barclays
United Kingdom
$65K +$85.8K +1,522 +2,342%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$56K – – –
AIG
36
American International Group
New York
$24K +$620 +11 +2%
SO
37
STRS Ohio
Ohio
$10K – – –
Citigroup
38
Citigroup
New York
$10K +$6.59K +117 +92%
Legal & General Group
39
Legal & General Group
United Kingdom
$8K – – –
CCA
40
Catalyst Capital Advisors
New York
$6K – – –
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$5K – – –
TRCT
42
Tower Research Capital (TRC)
New York
$5K +$2.25K +40 +56%
AIP
43
Ameritas Investment Partners
Nebraska
$3K – – –
MAM
44
Meeder Asset Management
Ohio
$2K +$2.2K +39 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$2K +$2.37K +42 New
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$1.2K – – –
Point72 Asset Management
47
Point72 Asset Management
Connecticut
– -$2.15M -37,500 Closed
KeyBank National Association
48
KeyBank National Association
Ohio
– -$195K -3,400 Closed
SIM
49
Spark Investment Management
New York
– -$186K -3,250 Closed
CSS
50
Cubist Systematic Strategies
Connecticut
– -$90K -1,568 Closed
1
2
3

COGT Hedge Fund Activity: Q3 2018 in Review

48 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q3 2018, worth a combined $158M — down 26% from $212M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new COGT positions and 6 closed out — a net gain of 4 holders — while 14 added to existing stakes and 12 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $989K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $2.15M sold.

  • 48 institutional investors held Cogent Biosciences (COGT) as of Q3 2018, up from 44 in Q2 2018.
  • Funds reported $158M of Cogent Biosciences stock for Q3 2018, down 26% quarter-over-quarter.
  • 10 funds opened new Cogent Biosciences positions in Q3 2018 and 6 closed out, a net change of +4 holders.
  • The largest Cogent Biosciences buyer in Q3 2018 was Renaissance Technologies, an estimated $989K added.
  • The largest Cogent Biosciences seller in Q3 2018 was Point72 Asset Management, an estimated $2.15M sold.

Based on aggregated 13F filings for Q3 2018.